Evidence map›Paper›PMID 40503500›Full record

ArticleThe Korean journal of helicobacter and upper gastrointestinal research2023

Types of 23S Ribosomal RNA Point Mutations Affecting

Gihong Park, Bokyung Kim, Hyunsoo Chung, Sang Gyun Kim, Soo-Jeong Cho

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Korean journal of helicobacter and upper gastrointestinal research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Research Status and Prospects ofGastroenterology research and practice · 2026
    Review
  3. Article
  4. [Does Types of 23S-Ribosomal RNA Point Mutations AffectThe Korean journal of helicobacter and upper gastrointestinal research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gihong ParkDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID 0009-0003-0632-2684
Bokyung KimDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-9143-9654
Hyunsoo ChungDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-5159-357X
Sang Gyun KimDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0003-1799-9028
Soo-Jeong ChoDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-7144-0589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The A2142G and A2143G mutations in the 23S ribosomal ribonucleic acid (rRNA) of Methods: Data from a previous randomized controlled trial were analyzed retrospectively. Eradication rates were compared based on the presence of Results: No significant difference was observed in Conclusions: The A2143G mutation may play a more significant role in clarithromycin triple therapy

Indexed as

ClarithromycinDrug resistance, microbialHelicobacter pyloriPolymerase chain reaction

Identifiers

PMID40503500
PMCPMC11967518

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.